Suppr超能文献

用于治疗结直肠癌的包裹在藻酸盐珠中的脂质体的研制。

Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer.

作者信息

Bansal Divya, Gulbake Arvind, Tiwari Jyoti, Jain Sanjay K

机构信息

Pharmaceutics Research Laboratory, Shri Ram Institute of Technology, Faculty of Pharmacy, Jabalpur, MP, India.

Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, India.

出版信息

Int J Biol Macromol. 2016 Jan;82:687-95. doi: 10.1016/j.ijbiomac.2015.09.052. Epub 2015 Oct 14.

Abstract

BACKGROUND

Folic Acid conjugated liposomes encapsulating Oxaliplatin (L-OHP) were entrapped in alginate beads and further coated with Eudragit-S-100 for effective delivery to colon tumors.

METHODS

Liposomes were prepared by cast film method and folic acid was coupled on the surface of liposomes. They were further entrapped in alginate beads which were Eudragit coated for degradation in the colonic region. The prepared beads were characterized for shape and surface morphology, percentage entrapment efficiency and drug release studies. The in vitro drug release was investigated using a USP dissolution paddle type apparatus in different simulated gastrointestinal fluids. In vivo studies of the beads containing free drug, folic acid coupled and uncoupled liposomes bearing L-OHP was administered orally at the dose of 10mg L-OHP/kg body weight to tumor bearing NUDE/SCID mice.

RESULTS

γ-Scintigraphic study showed that Eudragit coated alginate beads entered into the colon of Balb/c mice between 4.20 and 4.50h after oral administration. In vivo data showed that folic acid coupled liposomes entrapped in alginate beads delivered 2.82 ± 0.58 and 21.52 ± 2.76 μg L-OHP/g tissues in the colon and tumor after 12h, reflecting its targeting potential to colon and tumor.

CONCLUSION

The results clearly demonstrate that Eudragit coated calcium alginate beads bearing folic acid coupled liposome can be used as a prospective carrier for drug delivery to colon specific tumor.

摘要

背景

将包裹奥沙利铂(L-OHP)的叶酸共轭脂质体包封在海藻酸钠珠中,并进一步用Eudragit-S-100包衣,以实现向结肠肿瘤的有效递送。

方法

通过流延膜法制备脂质体,并将叶酸偶联在脂质体表面。将它们进一步包封在海藻酸钠珠中,该海藻酸钠珠用Eudragit包衣以在结肠区域降解。对制备的珠子进行形状和表面形态、包封率百分比和药物释放研究的表征。使用USP溶出桨式装置在不同的模拟胃肠液中研究体外药物释放。对含有游离药物、叶酸偶联和未偶联的载有L-OHP的脂质体的珠子进行体内研究,以10mg L-OHP/kg体重的剂量口服给予荷瘤裸鼠/重症联合免疫缺陷小鼠。

结果

γ闪烁扫描研究表明,Eudragit包衣的海藻酸钠珠在口服给药后4.20至4.50小时之间进入Balb/c小鼠的结肠。体内数据显示,包封在海藻酸钠珠中的叶酸偶联脂质体在12小时后在结肠和肿瘤中分别递送2.82±0.58和21.52±2.76μg L-OHP/g组织,反映了其对结肠和肿瘤的靶向潜力。

结论

结果清楚地表明,载有叶酸偶联脂质体的Eudragit包衣的海藻酸钙珠可作为向结肠特异性肿瘤递送药物的潜在载体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验